NCT04950621View on ClinicalTrials.gov

Remimazolam and Endovascular Procedures of Cerebrovascular Diseases

NACompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

July 13, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

September 30, 2022

Conditions
Cerebrovascular DisordersAnesthesia
Interventions
DRUG

remimazolam

Remimazolam will be administered during induction and maintenance for general anesthesia.

DRUG

propofol

Propofol will be administered during induction and maintenance for general anesthesia.

Trial Locations (1)

710032

Xijing hospital, Xi'an

All Listed Sponsors
lead

Air Force Military Medical University, China

OTHER